Endometriózis: ki dolgozik rajta

Intézményenként egy kártya. Célpontra vagy országra szűkítheted a listát.

• Minden célpont
• VEGF 0
• CTNNB1 0
• PPAR 0
• PI3K 0
• TP53 0
• AKT 0
• NLRP3 0
• TNF 0
• IL-6 0
• MMP-9 0
• NRF2 0
• AMPK 0
• ERK 0
• HIF-1 0
• JAK 0
• mTOR 0
• PTEN 0
• SIRT1 0
• TLR4 0
• HSP90 0
• MAPK 0
• STAT3 0
• BRCA1 0
• COX-2 0
• CXCR4 0
• EGFR 0
• ESR1 0
• HMGB1 0
• IL-1 0
• PD-1 0
• PKM2 0
• STING 0
• TREM2 0
• YAP 0
• BAP1 0
• BCL-2 0
• BDNF 0
• BRCA2 0
• CCR5 0
• CGRP 1
• CSF1R 0
• FAK 0
• FGFR 0
• FOXP3 0
• G6PD 0
• GPX4 0
• JNK 0
• KRAS 1
• LAG-3 0
• MDM2 0
• MYC 0
• PARP 0
• PD-L1 0
• PDGFR 0
• PRMT5 0
• SGLT2 0
• TIGIT 0
• VHL 0

1+ intézményből 1, a friss publikációk és a nyitott vizsgálatok szerint rendezve. Ez nem minőségi rangsor.

Funded research projects that name this disease in their title, terms or summary and have not ended yet: who is funded, where, how much and until when. Organisations only; the funder's page has the details.

• NIH NINDS · RF1

  Neuroendocrine mechanisms of female chronic overlapping pain conditions (COPC)

  University of Arizona· Tucson, Egyesült Államok· 3 462 365 USD awarded in fiscal year 2026· until 2030. aug.

• NIH NICHD · R01

  Decoding Dysmenorrhea: Longitudinal Modeling of Pelvic Pain Phenotypes in Adolescents and Young Adults

  Mclean Hospital· Belmont, Egyesült Államok· 695 377 USD awarded in fiscal year 2026· until 2031. máj.

• NIH NIAID · R01

  Mycoplasma genitalium in Women: Natural History, Clinical Sequelae, and Host-Microbiome-Mediated Clearance

  University of Maryland Baltimore· Baltimore, Egyesült Államok· 804 984 USD awarded in fiscal year 2026· until 2031. aug.

• NIH NEI · R01

  Beyond the Eye: Nociplastic Pain as a Predictor of Treatment Response in Chronic Ocular Surface Pain

  University of Michigan at Ann Arbor· Ann Arbor, Egyesült Államok· 690 677 USD awarded in fiscal year 2026· until 2031. máj.

• NIH NICHD · R01

  A Randomized Trial of Vitamin D Supplementation to Reduce Fibroid Growth

  Boston University Medical Campus· Boston, Egyesült Államok· 754 653 USD awarded in fiscal year 2026· until 2031. márc.

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-GF

  Tracking the Intestinal Permeation and Circulation Effects of Environmental MicroPlastics (TRACE-MP)

  Queen Mary University of London· London, Egyesült Királyság· EU contribution 292 073 EUR· until 2029. jan.· 2 countries

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-ERC-POC

  Uro-Lieve: Slow-Release Capsaicin Hydrogel for Disease-Modifying Therapy of Painful Bladder Syndrome

  University of Galway· Galway, Írország· EU contribution 150 000 EUR· until 2027. nov.

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-ERC-POC

  Simultaneous Yield of Non-invasive uterine Contractions via Wearable Observation and Real-time Monitoring A wearable platform for dynamic uterine motion capture. (SyncWorm)

  Gottfried Wilhelm Leibniz Universitaet Hannover· Hannover, Németország· EU contribution 150 000 EUR· until 2027. nov.

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-SE

  Untapping the potential for improved female reproductive healthcare: diagnosing and reinforcing the status of UTERINE-associated fertility (TULIP)

  Karolinska Institutet· Stockholm, Svédország· EU contribution 1 803 600 EUR· until 2029. dec.· 6 countries

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-EF

  Investigating how somatic mutation induced changes in the eutopic endometrial microenvironment cause endometriosis (MERMAID)

  Stichting Radboud Universitair Medisch Centrum· Nijmegen, Hollandia· EU contribution 232 916 EUR· until 2027. dec.

10 of 148 running projects, newest first. Listed amounts together: 90,0 M USD + 27,6 M EUR.

Sources: NIH RePORTER (U.S. National Institutes of Health, public domain) and CORDIS (European Commission, CC BY 4.0). Changes: filtered by disease, organisations matched to ROR.

Vizsgálatok, amelyek regiszteradata szerint az egyéni résztvevői adatokat (IPD) megosztják.

Ebben a nézetben egy vizsgálat sem jelzi, hogy megosztaná a résztvevői adatokat.

Publikációk erről a betegségről egy MeSH-módszerkifejezés szerint, például szekvenálási vagy képalkotó módszerre.

• Single-Cell Analysis 21
• Organoids 13
• Mendelian Randomization Analysis 29
• CRISPR-Cas Systems 1
• Gene Expression Profiling 44
• Sequence Analysis, RNA 6
• Exome Sequencing 2
• Proteomics 12
• Metabolomics 7
• Mass Spectrometry 2
• Flow Cytometry 7
• Immunohistochemistry 18
• Liquid Biopsy 1
• Xenograft Model Antitumor Assays 1
• Positron-Emission Tomography 3
• Magnetic Resonance Imaging 53
• Machine Learning 31
• Deep Learning 4
• Cohort Studies 48
• Genome-Wide Association Study 34

• Proteomic Profiling of Endometriosis and Ovarian Endometrioid Carcinoma: A Preliminary Exploratory Study.

  Technol Cancer Res Treat, 2026. okt.

• Multi-omics profiling identifies an immunometabolic signature associated with endometriosis.

  Front Endocrinol (Lausanne), 2026. aug.

• Translational Assessment of Omics Approaches in Endometriosis: Bridging Molecular Discovery with Clinical Utility.

  Int J Mol Sci, 2026. máj.

• Proteomic Analysis of Cervicovaginal Fluid for Diagnostic Endometriosis Biomarker Discovery.

  Proteomics Clin Appl, 2026. máj.

• Multi-ancestry genome-wide association and integrated multi-omics analyses of endometriosis and its clinical manifestations.

  Nat Genet, 2026. ápr.

• Plasma proteomic signature of the human menstrual cycle.

  Nat Med, 2026. ápr.

• Targeting HSP90 as a therapeutic approach for endometriosis: insights from proteomic analysis.

  Reproduction, 2026. febr.

• Identification of candidate microRNA biomarkers of endometriosis in different bodily fluids.

  Sci Rep, 2026. jan.

• Identifying Novel Biomarkers and Therapeutic Targets for Endometriosis: Integrative Analysis of the Plasma Proteome and Genome.

  Mediators Inflamm, 2026. jan.

• Metabolome analysis as a potential source of endometriosis biomarkers with the use of multiomics approach in its diagnosis.

  Sci Rep, 2025. nov.

Megmutatjuk, a betegség mely célpontjait említi az absztrakt, és onnan a rajtuk dolgozókhoz jutsz.